Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Omar A. Almohammed"'
Autor:
Abdulrahman Alwhaibi, Fawaz Alasmari, Faris Almutairi, Mohammed A. Assiri, Feras S. Aldawsari, Saud T. Aloyayd, Abdullah A. Alhejji, Jawaher A. Alotaibi, Abdulrazaq Albilali, Omar A. Almohammed, Sary Alsanea
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-16 (2024)
Abstract Background Fasting-induced headaches (FIHs) have been shown to occur on the first day of Ramadan and clearly decline thereafter. Despite the wealth of knowledge about different types of headaches (e.g., migraine-, cluster-, and tension-type
Externí odkaz:
https://doaj.org/article/539eebfce84a4b56a3a292e2236de6de
Autor:
Abdulaali R. Almutairi, Walaa A. Alshahrani, Ghaida K. Alhathlol, Fatimah Alsheikh, Abdulaziz Alakeel, Majed S. Al Yami, Mohammad Fouda, Omar A. Almohammed, Meshal S. Alhamed, Awatif Hafiz, Hussam Kutbi, Alaa Bagalagel, Aisha Alharbi, Mashael Alaboud, Sarah Aljohani, Waddah Ashram
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 12, Pp 102203- (2024)
Introduction: Evolocumab’s short-term efficacy and safety were proven in phase-3 clinical trial, but its long-term safety and effectiveness in the Saudi population are yet to be studied. The aim of this study was to assess the long-term safety and
Externí odkaz:
https://doaj.org/article/f13343917f36432888fdeb2e6d6bb801
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundLaws and regulations are needed to regulate the growing online pharmacy (OP) services. The main objective of this work was to provide an overview of the laws and regulations for OP services in the Gulf Cooperation Council (GCC) countries. I
Externí odkaz:
https://doaj.org/article/3b8404ed452a4bb997c3d28f7554f3f5
Autor:
Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Samiah Alsohimi, Rahaf Alqahtani, Saeedah Alfaifi, Aisha Alharbi, Azzah AlKhayrat, Ahmed Hattan, Meshal Albassam, Omar A. Almohammed, Atheer Alkeraidees, Dhay A. Alonazi, Weam F. Alsalman, Ghaliah Aldamegh, Rasha Alshahrani, Ramesh Vishwakarma
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract The use of tocilizumab for the management of COVID-19 emerged since it modulates inflammatory markers by blocking interleukin 6 receptors. Concerns regarding higher thrombosis risk while using tocilizumab were raised in the literature. The a
Externí odkaz:
https://doaj.org/article/9da835e4fbf34006bcb8aac9dd69d3b0
Autor:
Omar A. Alshaya, Ghazwa B. Korayem, Munirah Alghwainm, Wed Alyami, Albandari Alotaibi, Majed S. Alyami, Omar A. Almohammed
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102054- (2024)
Background: Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney disease (CKD), and obesity are associated with increased morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Nonetheless, their preva
Externí odkaz:
https://doaj.org/article/8d6b18b7d7c449c6995037f0ecdd896f
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 4, Pp 102022- (2024)
Background: Single nucleotide polymorphisms in the gene encoding proteins involved in mercaptopurine metabolism can influence drug efficacy and safety. This study aims to assess clinical pharmacists’ knowledge about mercaptopurine-related genes and
Externí odkaz:
https://doaj.org/article/861252181804472da19c2aabd835a132
Autor:
Marwan A. Alrasheed, Khalid A. Alamer, Mashael Albishi, Abdulrahman A. Alsuhibani, Omar A. Almohammed, Abdulrahman Alwhaibi, Abdullah N. Almajed, Jeff J. Guo
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 815 (2024)
Background: New multiple myeloma (MM) medications have revolutionized the treatment landscape, but they are also associated with a range of adverse events (AEs). This study aims to provide a comprehensive overview of AEs reported for four new MM medi
Externí odkaz:
https://doaj.org/article/5cb04df204e946929d17126293472b9f
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 4, Pp 517-525 (2023)
Purpose: The purpose of this study was to evaluate the effectiveness of either hydroxychloroquine, triple combination therapy (TCT), favipiravir, dexamethasone, remdesivir, or COVID-19 convalescent plasma (CCP) in comparison with standard-of-care for
Externí odkaz:
https://doaj.org/article/1f959fe8f110441a844fd7007718b0ab
Autor:
Omar A. Almohammed, Rawan A. Alnogaidan, Fatmah O. Ghannam, Reem S. Alqahtani, Shoug K. Aloraini, Norah O. Abanmy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 8, Pp 101676- (2023)
Purpose: Online pharmacies (OPs) represent a growing field that plays a major role in providing pharmaceutical services in Saudi Arabia (SA). Thus, investigating public awareness of this option and assessing consumers’ experiences and satisfaction,
Externí odkaz:
https://doaj.org/article/152b4bb1132e46559d093e4d20116e58
Autor:
Majed S. Al Yami, Asma H. Qudayr, Lina M. Alhushan, Fatemah M. Hakami, Ghazwa B. Korayem, Omar A. Alshaya, Omar A. Almohammed
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 8, Pp 101673- (2023)
Background: Since the risk of recurrence of venous thromboembolism (VTE) increases with duration or inadequate anticoagulation dosage, a proper regimen of apixaban and rivaroxaban is essential in patients with VTE, especially during the acute phase.
Externí odkaz:
https://doaj.org/article/fab48d494cf54d03a7839545b3bbab1c